Steve Hurley

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

B. Pitt, F. Zannad, W. Remme, 2003 .

The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction

J. López-Sendón, B. Pitt, F. Zannad, 2004, Cardiovascular Drugs and Therapy.

Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction

B. Pitt, F. Zannad, W. Remme, 2003 .

Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study).

J. Spertus, B. Pitt, P. Deedwania, 2002, American heart journal.

EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION

B. Pitt, F. Zannad, W. Remme, 2003 .

EFFECTS OF PREPUBERTAL STRESS ON SUBSEQUENT ACTH RESPONSE TO NOVEL STRESS AND CRH IN MALE VS FEMALE RATS

Steve Hurley, G. Crawford, J. Bennett, 1996 .

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

B. Pitt, F. Zannad, W. Remme, 2003, The New England journal of medicine.